Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC and MC Infusion in Type 2 Diabetes Mellitus
NCT01719640Phase 2Completed
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Jan 2011
- Primary completion
- Jan 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow mesenchymal stem cells, bone marrow mononuclear cells in type 2 diabetes mellitus (T2DM), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Started Jan 2011; status: completed.
02
Drugs
bone marrow mesenchymal stem cellsbone marrow mononuclear cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01719640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01719640.